➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Boehringer Ingelheim
AstraZeneca
Dow
Mallinckrodt

Last Updated: July 30, 2021

DrugPatentWatch Database Preview

Details for Patent: 8,546,367


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,546,367 protect, and when does it expire?

Patent 8,546,367 protects KYBELLA and is included in one NDA.

This patent has sixty-one patent family members in thirty countries.

Summary for Patent: 8,546,367
Title:Synthetic bile acid compositions and methods
Abstract: Bile acids and related compositions and methods of synthesis and use. More specifically, deoxycholic acid and related compositions, said compositions being free of all moieties of animal origin and free of pyrogenic moieties.
Inventor(s): Moriarty; Robert M. (Michiana City, IN), David; Nathaniel E. (Los Angeles, CA), Mahmood; Nadir Ahmeduddin (Calabasas, CA)
Assignee: Kythera Biopharmaceuticals, Inc. (Calabasas, CA)
Application Number:13/486,945
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,546,367
Patent Claim Types:
see list of patent claims
Composition; Use;

Drugs Protected by US Patent 8,546,367

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Kythera Biopharms KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 AP RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y METHOD FOR REDUCTION OF SUBMENTAL FAT ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,546,367

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 067440 ⤷  Free Forever Trial
Argentina 112325 ⤷  Free Forever Trial
Australia 2008265721 ⤷  Free Forever Trial
Brazil PI0813140 ⤷  Free Forever Trial
Canada 2690841 ⤷  Free Forever Trial
Canada 2789109 ⤷  Free Forever Trial
Chile 2008001783 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Harvard Business School
Johnson and Johnson
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.